デフォルト表紙
市場調査レポート
商品コード
1310231

テレファーマシー市場:サービス別(薬局コンサルテーション、リモートオーダーエントリー)、エンドユース別(病院、プライマリケアセンター)-世界予測2023-2030年

Telepharmacy Market by Services (Pharmacy Consultation, Remote Order Entry), End-Use (Hospitals, Primary Care Centers) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
テレファーマシー市場:サービス別(薬局コンサルテーション、リモートオーダーエントリー)、エンドユース別(病院、プライマリケアセンター)-世界予測2023-2030年
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

テレファーマシーの世界市場は、2023年にCAGR 10.01%で10億4,668万米ドルと予測され、2030年には20億4,374万米ドルと驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のテレファーマシー市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.テレファーマシーの世界市場規模および予測は?

2.予測期間中、世界のテレファーマシー市場を形成するCOVID-19の阻害要因と影響は?

3.テレファーマシーの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.テレファーマシーの世界市場における競争戦略は?

5.テレファーマシーの世界市場における技術動向と規制の枠組みは?

6.テレファーマシーの世界市場における主要ベンダーの市場シェアは?

7.テレファーマシーの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 遠隔医療と遠隔医療の影響力の増大
      • インターネット普及率の増加とインターネットユーザーの増加
      • コスト削減と運用効率の向上別メリット
    • 抑制要因
      • テレファーマシーに関する法令の違い
    • 機会
      • 遠隔地で必須医薬品を利用する取り組みが増加
      • 効率的なテレファーマシーサービスを提供するための戦略的提携
    • 課題
      • 認知度が低く、インフラストラクチャのサポートが限られている
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 テレファーマシー市場:サービス別

  • 薬局相談
  • リモート注文入力

第7章 テレファーマシー市場:最終用途別

  • 病院
  • プライマリケアセンター

第8章 南北アメリカのテレファーマシー市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のテレファーマシー市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのテレファーマシー市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. TELEPHARMACY MARKET RESEARCH PROCESS
  • FIGURE 2. TELEPHARMACY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. TELEPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. TELEPHARMACY MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
  • FIGURE 5. TELEPHARMACY MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
  • FIGURE 6. TELEPHARMACY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. TELEPHARMACY MARKET DYNAMICS
  • FIGURE 8. TELEPHARMACY MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. TELEPHARMACY MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS TELEPHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES TELEPHARMACY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. TELEPHARMACY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. TELEPHARMACY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. TELEPHARMACY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. TELEPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 5. TELEPHARMACY MARKET SIZE, BY PHARMACY CONSULTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. TELEPHARMACY MARKET SIZE, BY REMOTE ORDER ENTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 8. TELEPHARMACY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. TELEPHARMACY MARKET SIZE, BY PRIMARY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AMERICAS TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 13. ARGENTINA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 15. BRAZIL TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. CANADA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. MEXICO TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. UNITED STATES TELEPHARMACY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. AUSTRALIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. CHINA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. INDIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. INDONESIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. JAPAN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. MALAYSIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. PHILIPPINES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. SINGAPORE TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. SOUTH KOREA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. TAIWAN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. THAILAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. VIETNAM TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. DENMARK TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. EGYPT TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. FINLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. FRANCE TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. GERMANY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. ISRAEL TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. ITALY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. NETHERLANDS TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. NIGERIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. NORWAY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. POLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. QATAR TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. RUSSIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. SAUDI ARABIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH AFRICA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SPAIN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. SWEDEN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SWITZERLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. TURKEY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED ARAB EMIRATES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED KINGDOM TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. TELEPHARMACY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 97. TELEPHARMACY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 98. TELEPHARMACY MARKET LICENSE & PRICING
目次
Product Code: MRR-0360AB17E1DE

The Global Telepharmacy Market is forecasted to grow significantly, with a projected USD 1,046.68 million in 2023 at a CAGR of 10.01% and expected to reach a staggering USD 2,043.74 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Telepharmacy Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Telepharmacy Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Services, market is studied across Pharmacy Consultation and Remote Order Entry. The Pharmacy Consultation is projected to witness significant market share during forecast period.

Based on End-Use, market is studied across Hospitals and Primary Care Centers. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Telepharmacy Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Telepharmacy Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Telepharmacy Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Telepharmacy Market?

4. What is the competitive strategic window for opportunities in the Global Telepharmacy Market?

5. What are the technology trends and regulatory frameworks in the Global Telepharmacy Market?

6. What is the market share of the leading vendors in the Global Telepharmacy Market?

7. What modes and strategic moves are considered suitable for entering the Global Telepharmacy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Telepharmacy Market, by Services, 2022 vs 2030
  • 4.3. Telepharmacy Market, by End-Use, 2022 vs 2030
  • 4.4. Telepharmacy Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising influence of telemedicine and telehealth
      • 5.1.1.2. Growth in internet penetration coupled with rising internet users
      • 5.1.1.3. Benefits of cost savings and operational efficiencies
    • 5.1.2. Restraints
      • 5.1.2.1. Differences in laws and regulations related to telepharmacy
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing approach to avail the essential drugs in remote areas
      • 5.1.3.2. Strategic alliances to provide efficient telepharmacy services
    • 5.1.4. Challenges
      • 5.1.4.1. Less awareness and limited infrastructure support
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Telepharmacy Market, by Services

  • 6.1. Introduction
  • 6.2. Pharmacy Consultation
  • 6.3. Remote Order Entry

7. Telepharmacy Market, by End-Use

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Primary Care Centers

8. Americas Telepharmacy Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Telepharmacy Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Telepharmacy Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing